Wall Street Journal Examines NIH Funding for Anti-Bioterrorism Medications, Vaccines The Wall Stree Journal on Tuesday examined the role Anthony Fauci, director of the NIH National Institute of Allergy and Infectious Diseases, has played since the Sept. 11, 2001, attacks to direct funding to drug companies to produce biodefense medicines. After the terrorist and anthrax attacks, Fauci argued that NIAID was “well-suited to receive new funds for biodefense,” and the agency’s biodefense-related funding rose from $42 millionRead More→